Should a Multigene Signature be Used in all Luminal Early Breast Cancers
Author:
Publisher
Frontiers Media SA
Subject
Cancer Research,Oncology
Reference37 articles.
1. Practical implications of gene-expression-based assays for breast oncologists;Prat;Nat Rev Clin Oncol.,2011
2. Use of biomarkers to guide decisions on adjuvant systemic therapy for women with early-stage invasive Breast Cancer;Harris;Am Soc Clin Oncol Clin Prac Guideline.,2016
3. Breast Cancer-Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual;Giuliano;CA Cancer J Clin.,2017
4. New prognostic factors for breast cancer recurrence;Isaacs;Semin Oncol.,2001
5. Identifying clinically relevant prognostic subgroups of postmenopausal women with node-positive hormone receptor-positive early-stage breast cancer treated with endocrine therapy: a combined analysis of ABCSG-8 and ATAC using the PAM50 risk of recurrence score and intrinsic subtype;Gnant;Ann Oncol.,2015
Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Concordance between results of inexpensive statistical models and multigene signatures in patients with ER+/HER2− early breast cancer;Modern Pathology;2021-02-08
2. A Phenomic Perspective on Factors Influencing Breast Cancer Treatment: Integrating Aging and Lifestyle in Blood and Tissue Biomarker Profiling;Frontiers in Immunology;2021-02-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3